You are currently viewing a new version of our website. To view the old version click .

Biologics, Volume 5, Issue 4

December 2025 - 6 articles

  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (6)

  • Article
  • Open Access

3 November 2025

Background: Various thiolactones are known as biologically active compounds, capable of stimulating the development of several human diseases and quorum sensing of Gram–positive bacteria. The enzymatic hydrolysis of thiolactones represents a pr...

  • Article
  • Open Access
402 Views
11 Pages

22 October 2025

Background/Objectives: Omalizumab is a monoclonal anti-IgE antibody approved for the treatment of chronic urticaria. There are no established or validated prognostic markers currently available to identify likely responders. The aim of this study was...

  • Article
  • Open Access
359 Views
25 Pages

13 October 2025

Background/Objectives: Obesity increases reactive oxygen species (ROS), thereby triggering oxidative stress. Coriander seeds contain polyphenolic compounds that act as natural antioxidants to reduce oxidative stress. Coriander seed ethanolic extract...

  • Article
  • Open Access
530 Views
15 Pages

11 October 2025

Background/Objectives: Sera from patients before and after organ transplantation were tested at two different temperatures, 21 °C and 37 °C. Currently, organs are transported under normothermic conditions (37 °C). This observational pilot...

  • Case Report
  • Open Access
347 Views
7 Pages

Rituximab-Associated Myocardial Injury in a Young Woman with Granulomatosis with Polyangiitis: A Case Report

  • Natasha E. Barton,
  • Elizabeth A. Stein,
  • Kathryn Mulvaney and
  • Yevgeniya Scherbak

10 October 2025

Background: Rituximab is a monoclonal antibody targeting CD20, commonly used to treat autoimmune diseases such as granulomatosis with polyangiitis (GPA) and rheumatoid arthritis. While generally well-tolerated, serious adverse events, including infus...

  • Article
  • Open Access
409 Views
38 Pages

29 September 2025

Background and Objectives: Probiotics are live microorganisms that promote health when consumed in adequate amounts, ensure the balance of bacterial composition in the digestive system, and suppress harmful pathogenic bacteria, with overall implicati...

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Biologics - ISSN 2673-8449Creative Common CC BY license